NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 132 filers reported holding NOVAVAX INC in Q4 2013. The put-call ratio across all filers is 2.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,276,000 | -78.9% | 2,315,768 | -29.5% | 0.00% | -83.3% |
| Q4 2018 | $6,040,000 | +216.7% | 3,282,564 | +223.6% | 0.02% | +380.0% |
| Q3 2018 | $1,907,000 | -22.0% | 1,014,484 | -44.4% | 0.01% | -28.6% |
| Q2 2018 | $2,445,000 | +370.2% | 1,824,816 | +637.5% | 0.01% | +250.0% |
| Q1 2018 | $520,000 | +141.9% | 247,435 | +42.5% | 0.00% | +100.0% |
| Q4 2017 | $215,000 | +424.4% | 173,605 | +436.4% | 0.00% | – |
| Q4 2016 | $41,000 | -59.0% | 32,366 | +136.2% | 0.00% | – |
| Q2 2016 | $100,000 | -97.2% | 13,700 | -97.3% | 0.00% | -100.0% |
| Q3 2015 | $3,630,000 | +7966.7% | 513,380 | +3499.6% | 0.02% | – |
| Q3 2013 | $45,000 | – | 14,262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |